Rebecca Rohlfs

Rebecca Rohlfs, Ph.D., is a Senior Scientist at Novo Nordisk since November 2020, with previous experience as a Senior Scientist at Alkermes from August 2016 to November 2020, focusing on bioanalytical development. Prior roles include a Research Associate at Cincinnati Children's Hospital Medical Center, where research involved proteomics related to cystic fibrosis, and a Senior Scientist I at Merial, a Sanofi Company, responsible for analytical method development. Education includes a Ph.D. in Bioanalytical Chemistry from the University of Cincinnati and a BS in Chemistry from Xavier University. Dissertation research concentrated on liquid chromatography and mass spectrometry analysis of post-transcriptional modifications of rRNA.